NEWS

Telix gets the nod for phase two leukemia study

MELBOURNE: Pharmaceuticals developer Telix has been given the green light to launch a ... read more

Osprey trims losses 12 per cent to $US6.5M

MELBOURNE: Medtech Osprey has unveiled half-year revenues up by one third to $US1.1 ... read more

Star loses revenue but ‘remains open’ to Crown deal

SYDNEY: Star Entertainment has taken a hit of 6.5 per cent to revenue ... read more

The Star shines on plans to sell casino properties

SYDNEY: Casino operator The Star’s share price is soaring after it said it ... read more